脏疾病和心力衰竭:最近的进展和当前的挑战:从脏疾病的结论:改善全球结果 (KDIGO) 争议会议会议
Carolyn S P Lam1, Biykem Bozkurt2, David Z I Cherney3
1National Heart Centre Singapore and Duke-National University of Singapore, Singapore.
Kidney international
|March 6, 2026
概括
心力衰竭 (HF) 和慢性病 (CKD) 经常并存,增加健康风险. 综合管理策略对于改善患者的治疗结果至关重要,考虑到共同的风险因素和量身定制的治疗方法.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 翻译医学是一种翻译医学.
背景情况:
- 心力衰竭 (HF) 和慢性病 (CKD) 经常同时存在,导致住院治疗,疾病进展和死亡率增加.
- 尽管在个体疾病治疗方面取得了进展,但管理联合HF和CKD存在诊断和治疗方面的挑战.
研究的目的:
- 讨论心力衰竭和慢性病同时存在的患者管理的最新进展和当前挑战.
- 要突出HF和CKD之间的复杂,双向关系,包括共享的病理生理学和生物标志物解释.
主要方法:
- 病:改善全球结果 (KDIGO) 争议会议于2024年3月召开专家会议.
- 讨论的重点是共同的风险因素,重叠的病理生理学,生物标志物的解释,以及对HF和CKD的治疗策略.
主要成果:
- -葡萄糖共传输体-2 抑制剂,氨酸-血管酶-阿尔多斯特系统抑制剂和其他药物对HF和CKD患者都很有前途,尽管晚期CKD的证据有限.
- 在HF治疗开始期间,小的,由血液动力学驱动的功能下降通常不是停止治疗的原因.
- 强调需要针对慢性病的HF诊断值,以及在HF中改进急性损伤的定义.
结论:
- 对于患有HF和CKD的患者来说,具有共同治疗目标的综合,个性化的管理方法至关重要.
- 未来的试验应纳入脏特定的终点,症状负担和生活质量措施,以更好地告知治疗策略.
相关概念视频
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...